Colt CZ Group (CZG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jun, 2025Executive summary
Achieved record Q1 2025 revenues of CZK 5,512 million, up 50.3% year-over-year, and adjusted EBITDA of CZK 1,212 million, up 148.1% year-over-year.
Profit for the period rose 73% to CZK 523.9 million; comprehensive income reached CZK 547.5 million.
Growth driven by S&B acquisition, strong ammunition segment profitability, and double-digit US market growth.
The Group operates two main segments: Firearms & Accessories and Ammunition, both contributing significantly to growth.
Net leverage ratio improved to 2.04x, reflecting a stronger financial position.
Financial highlights
Revenues increased 50.3% year-over-year to CZK 5,512 million; adjusted EBITDA margin reached 22%.
Operating profit increased to CZK 819.5 million from CZK 220.8 million year-over-year.
Net cash from operating activities was CZK 992.1 million, up from an outflow of CZK 555.4 million in Q1 2024.
Own production accounted for CZK 2,667 million in firearms (14% margin) and CZK 2,475 million in ammunition (33% margin).
Cash and cash equivalents rose to CZK 6.34 billion from CZK 5.92 billion at year-end.
Outlook and guidance
FY 2025 revenue guidance: CZK 25 billion (±10%); adjusted EBITDA: CZK 5.5 billion (±10%).
No revision to 2025 guidance yet, pending assessment of U.S. tariff impacts and commercial market developments.
Board proposes CZK 847 million dividend (CZK 15/share) and CZK 847 million share buyback for 2024.
Net interest costs expected at CZK 634 million; CAPEX guidance CZK 1,100–1,300 million.
Mitigation strategies for tariffs include price adjustments, product mix changes, and export redirection.
Latest events from Colt CZ Group
- Net profit surged as ammunition growth offset U.S. firearms weakness; 2026 set for major gains.CZG
Q4 202525 Mar 2026 - Revenue and net profit surged, with acquisitions and bond issuance fueling future growth.CZG
Q3 202520 Nov 2025 - Ammunition-led growth and acquisitions drove higher revenues, with 2025 outlook reaffirmed.CZG
Q2 202518 Sep 2025 - Revenue up 51%, but net profit down on acquisition costs; guidance and leverage targets met.CZG
Q3 202413 Jun 2025 - Record H1 2024 revenue and EBITDA growth driven by Sellier & Bellot acquisition and US recovery.CZG
Q2 202413 Jun 2025 - 2024 revenue up 50.6% to CZK 22.4bn, with 2025 growth and profit distribution split expected.CZG
Q4 20249 Jun 2025